Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis

Addiction

Volumn 105, Issue 12, 2010, Pages 2071-2084

  Cleary, Brian J ^a,b,c   Donnelly, Jean ^a   Strawbridge, Judith ^b   Gallagher, Paul J ^b   Fahey, Tom ^b   Clarke, Mike ^c,d   Murphy, Deirdre J ^a,c  

^a Pathology Research Laboratory   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d UK COCHRANE CENTRE   (United Kingdom)

Author keywords

Meta analysis; Methadone; Neonatal abstinence syndrome; Neonate; Pregnancy; Systematic review; Withdrawal

Indexed keywords

METHADONE; NARCOTIC AGENT;

BIBLIOGRAPHIC DATABASE; COHORT ANALYSIS; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; META ANALYSIS; NEWBORN; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WITHDRAWAL SYNDROME;

COHORT STUDIES; DATABASES, BIBLIOGRAPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT, NEWBORN; METHADONE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 78249244484     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03120.x     Document Type: Review

References (105)

1. Department of Health (England) and the Devolved Administrations. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health (England), The Scottish Government, Welsh Assembly Government, Northern Ireland Executive; 2007.
2. New South Wales Department of Health. National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn. Sydney: NSW Department of Health; 2006.
3. Batki S. L. K. J., Marion I., Parrino M. W., Woody G. E., Center for Substance Abuse Treatment (CSAT). Medication-Assisted Treatment for Opioid Addiction During Pregnancy. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment improvement protocol (TIP); no. 43. Rockville, MD: Substance Abuse and Mental Health Services Administration (SAMHSA); 2005, p. 211-24.
4. Kandall S. R., Doberczak T. M., Jantunen M., Stein J. The methadone-maintained pregnancy. Clin Perinatol 1999; 26: 173-83.
5. Hulse G. K., Milne E., English D. R., Holman C. D. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571-9.
6. Kaltenbach K., Jones H., Fischer G., Selby P. New approaches in the treatment of opioid dependency during pregnancy. Heroin Addict Relat Clin Probl 2007; 9: 9-19.
7. Finnegan L. P., Connaughton J. J. F., Kron R. E., Emich J. P. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2: 141-58.
8. Kaltenbach K., Finnegan L. P. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome. Neurobehav Toxicol Teratol 1986; 8: 353-5.
9. Jansson L. M., Svikis D. S., Velez M., Fitzgerald E., Jones H. E. The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse 2007; 42: 961-74.
10. Doberczak T. M., Kandall S. R., Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991; 118: 933-7.
11. Maas U., Kattner E., Weingart-Jesse B., Schafer A., Obladen M. Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med 1990; 18: 111-8.
12. Madden J. D., Chappel J. N., Zuspan F., Gumpel J., Mejia A., Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 1977; 127: 199-201.
13. Jones H. E., O'Grady K. E., Malfi D., Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008; 17: 372-86.
14. Burns L., Mattick R. P., Lim K., Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007; 102: 264-70.
15. Lim S., Prasad M. R., Samuels P., Gardner D. K., Cordero L. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol 2009; 200: 70 e1-5.
16. Dryden C., Young D., Hepburn M., Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Br J Obstet Gynaecol 2009; 116: 665-71.
17. Serane V. T., Kurian O. Neonatal abstinence syndrome. Indian J Pediatr 2008; 75: 911-4.
18. Heimann K., Bartz C., Silvestri A., Merz U., Hornchen H., Kentrup H. Methadone substitution during pregnancy: relationship between dose and effect in neonatal abstinence syndrome. Geburtsh Frauenheilkd 2006; 66: 277-83.
19. Arlettaz R., Kashiwagi M., Das-Kundu S., Fauchere J. C., Lang A., Bucher H. U. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 2005; 84: 145-50.
20. Scully M., Geoghegan N., Corcoran P., Tiernan M., Keenan E. Specialized drug liaison midwife services for pregnant opioid dependent women in Dublin, Ireland. J Subst Abuse Treat 2004; 26: 329-35.
21. Dashe J. S., Sheffield J. S., Olscher D. A., Todd S. J., Jackson G. L., Wendel G. D. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002; 100: 1244-9.
22. Sinha C., Ohadike P., Carrick P., Pairaudeau P., Armstrong D., Lindow S. W. Neonatal outcome following maternal opiate use in late pregnancy. Int J Gynaecol Obstet 2001; 74: 241-6.
23. Llewelyn R. Does methadone affect pregnancy outcome? J Obstet Gynaecol 1997; 17: 266-7.
24. Mayes L. C., Carroll K. M. Neonatal withdrawal syndrome in infants exposed to cocaine and methadone. Subst Use Misuse 1996; 31: 241-53.
25. Malpas T. J., Darlow B. A., Lennox R., Horwood L. J. Maternal methadone dosage and neonatal withdrawal. Aust NZ J Obstet Gynaecol 1995; 35: 175-7.
26. Fundaro C., Solinas A., Martino A. M., Genovese O., Noia G., Conte G. L. et al. [Neonatal abstinence syndrome and maternal toxicological profile]. Minerva Pediatr 1994; 46: 83-8.
27. Dawe S., Gerada C., Strang J. Establishment of a liaison service for pregnant opiate-dependent women. Br J Addict 1992; 87: 867-71.
28. Suffet F., Brotman R. A comprehensive care program for pregnant addicts: obstetrical, neonatal, and child development outcomes. Int J Addict 1984; 19: 199-219.
29. Olofsson M., Buckley W., Andersen G. E., Friis-Hansen B. Investigation of 89 children born by drug-dependent mothers. I. Neonatal course. Acta Paediatr Scand 1983; 72: 403-6.
30. Harper R. G., Solish G., Feingold E., Gersten-Woolf N. B., Sokal M. M. Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol 1977; 129: 417-24.
31. Ostrea E. M., Chavez C. J., Strauss M. E. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr 1976; 88: 642-5.
32. Strauss M. E., Lessen-Firestone J. K., Starr R. H. Jr, Ostrea E. M. Jr. Behavior of narcotics-addicted newborns. Child Dev 1975; 46: 887-93.
33. Davis R. C., Chappel J. N., Mejia-Zelaya A., Madden J. Clinical observations on methadone-maintained pregnancies. Addict Dis 1975; 2: 101-12.
34. Bakstad B., Sarfi M., Welle-Strand G. K., Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 2009; 15: 128-34.
35. Seligman N. S., Salva N., Hayes E. J., Dysart K. C., Pequignot E. C., Baxter J. K. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008; 199: 396.e1-e7.
36. Mayet S., Groshkova T., Morgan L., MacCormack T., Strang J. Drugs and pregnancy-outcomes of women engaged with a specialist perinatal outreach addictions service. Drug Alcohol Rev 2008; 27: 497-503.
37. Miles J., Sugumar K., Macrory F., Sims D. G., D'Souza S. W. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health Dev 2007; 33: 206-12.
38. Jansson L. M., Dipietro J. A., Elko A., Velez M. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J Matern Fetal Neonatal Med 2007; 20: 677-85.
39. Ebner N., Rohrmeister K., Winklbaur B., Baewert A., Jagsch R., Peternell A. et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007; 87: 131-8.
40. Lejeune C., Simmat-Durand L., Gourarier L., Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend 2006; 82: 250-7.
41. McCarthy J. J., Leamon M. H., Parr M. S., Anania B. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005; 193: 606-10.
42. Kuschel C. A., Austerberry L., Cornwell M., Couch R., Rowley R. S. Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome? Arch Dis Child Fetal Neonatal Ed 2004; 89: F390-3.
43. Berghella V., Lim P. J., Hill M. K., Cherpes J., Chennat J., Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 2003; 189: 312-7.
44. Geistlich S. Course of pregnancy and withdrawal symptoms in newborn infants of female methadone patients and women under morphine substitution treatment. In: Pregnancy and Drug Misuse, Strasbourg: Council of Europe Publishing; 1999, p. 67-84.
45. Hagopian G. S., Wolfe H. M., Sokol R. J., Ager J. W., Wardell J. N., Cepeda E. E. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med 1996; 5: 348-54.
46. Shaw N. J., McIvor L. Neonatal abstinence syndrome after maternal methadone treatment. Arch Dis Child Fetal Neonatal Ed 1994; 71: F203-5.
47. Mack G., Thomas D., Giles W., Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health 1991; 27: 96-100.
48. Stimmel B., Goldberg J., Reisman A., Murphy R. J., Teets K. Fetal outcome in narcotic-dependent women: the importance of the type of maternal narcotic used. Am J Drug Alcohol Abuse 1982; 9: 383-95.
49. Kandall S. R., Albin S., Gartner L. M., Lee K. S., Eidelman A., Lowinson J. The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev 1977; 1: 159-69.
50. Rosen T. S., Pippenger C. E. Disposition of methadone and its relationship to severity of withdrawal in the newborn. Addict Dis 1975; 2: 169-78.
51. Statzer D. E., Wardell J. N. Heroin addiction during pregnancy. Am J Obstet Gynecol 1972; 113: 273-8.
52. Stroup D. F., Berlin J. A., Morton S. C., Olkin I., Williamson G. D., Rennie D. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
53. Centre for Reviews and Dissemination (CRD). Systematic Reviews. CRD's Guidance for Undertaking Reviews in Health Care. York: University of York; 2009.
54. Sanderson S., Tatt I. D., Higgins J. P. T. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007; 36: 666-76.
55. Agency for Healthcare Research and Quality. Systems to Rate the Strength of Scientific Evidence. Evidence Report/Technology Assessment: Number 47. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2002.
56. Review Manager (RevMan) [Computer program], version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.
57. Higgins J. P. T., Thompson S. G., Deeks J. J., Altman D. G. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
58. Choo R. E., Huestis M. A., Schroeder J. R., Shin A. S., Jones H. E. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend 2004; 75: 253-60.
59. Jones H. E., Johnson R. E., Jasinski D. R., O'Grady K. E., Chisholm C. A., Choo R. E. et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005; 79: 1-10.
60. Fischer G., Ortner R., Rohrmeister K., Jagsch R., Baewert A., Langer M. et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006; 101: 275-81.
61. Strauss M. E., Andresko M., Stryker J. C., Wardell J. N. Relationship of neonatal withdrawal to maternal methadone dose. Am J Drug Alcohol Abuse 1976; 3: 339-45.
62. Finnegan L. P., Ehrlich K. Maternal drug use during pregnancy: evaluation and pharmacotherapy for neonatal abstinence. Mod Methods Pharmacol Test Eval Drugs Abuse 1990; 6: 255-63.
63. Lipsitz P. J. A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clin Pediatr 1975; 14: 592.
64. Rivers R. P. Neonatal opiate withdrawal. Arch Dis Child 1986; 61: 1236-9.
65. Green M., Suffet F. The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse 1981; 8: 203-13.
66. Blaser A., Pulzer F., Knupfer M., Robel-Tillig E., Vogtmann C., Nickel P. et al. [Drug withdrawal in newborns-clinical data of 49 infants with intrauterine drug exposure: what should be done?]. Klin Padiatr 2008; 220: 308-15.
67. Brown H. L., Britton K. A., Mahaffey D., Brizendine E., Hiett A. K., Turnquest M. A. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol 1998; 179: 459-63.
68. Davis R. C., Chappel J. N. Pregnancy in the context of narcotic addiction and methadone maintenance. Proc Natl Conf Methadone Treat 1973; 2: 1146-52.
69. Jansson L. M., Choo R., Velez M. L., Harrow C., Schroeder J. R., Shakleya D. M. et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008; 121: 106-14.
70. McCarthy J. E., Siney C., Shaw N. J., Ruben S. M. Outcome predictors in pregnant opiate and polydrug users. Eur J Pediatr 1999; 158: 748-9.
71. Newman R. G., Bashkow S., Calko D. Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program. Am J Obstet Gynecol 1975; 121: 233-7.
72. Jansson L. M., Dipietro J. A., Velez M., Elko A., Knauer H., Kivlighan K. T. Maternal methadone dosing schedule and fetal neurobehaviour. J Matern Fetal Neonatal Med 2009; 22: 29-35.
73. Blinick G. Menstrual function and pregnancy in narcotics addicts treated with methadone. Nature 1968; 219: 180.
74. Reddy A. M., Harper R. G., Stern G. Observations on heroin and methadone withdrawal in the newborn. Pediatrics 1971; 48: 353-8.
75. Cohen S. N., Neumann L. L. Methadone maintenance during pregnancy. Am J Dis Child 1973; 126: 445-6.
76. Drozdick J., 3rd, Berghella V., Hill M., Kaltenbach K. Methadone trough levels in pregnancy. Am J Obstet Gynecol 2002; 187: 1184-8.
77. Jarvis M. A., Wu-Pong S., Kniseley J. S., Schnoll S. H. Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999; 18: 51-61.
78. Dashe J. S., Sheffield J. S., Wendel G. D. Improving the management of opioid-dependent pregnancies. Am J Obstet Gynecol 2004; 190: 1806.
79. Minozzi S., Amato L., Vecchi S., Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 2008; 2: CD006318.
80. Osborn D. A., Jeffery H. E., Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2005; 3: CD002059.
81. Osborn D. A., Jeffery H. E., Cole M. J. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2005; 3: CD002053.
82. Wang E. C. Methadone treatment during pregnancy. J Obstet Gynecol Neonatal Nurs 1999; 28: 615-22.
83. Rayburn W. F., Bogenschutz M. P. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol 2004; 191: 1885-97.
84. Winklbaur B., Jung E., Fischer G. Opioid dependence and pregnancy. Curr Opin Psychiatry 2008; 21: 255-9.
85. Hulse G., Milne E., English D., Holman C. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998; 93: 1033-42.
86. Blinick G., Inturrisi C. E., Jerez E., Wallach R. C. Methadone assays in pregnant women and progeny. Am J Obstet Gynecol 1975; 121: 617-21.
87. Brulet C., Chanal C., Ravel P., Mazurier E., Boulot P., Faucherre V. Multidisciplinary monitoring and psychosocial support reduce complications of opiate dependence in pregnant women: 114 pregnancies. Presse Med 2007; 36: 1571-80.
88. Chasnoff I. J., Burns W. J., Schnoll S. H. Perinatal addiction: the effects of maternal narcotic and nonnarcotic substance abuse on the fetus and neonate. NIDA Res Monogr 1984; 49: 220-6.
89. Davis M. M., Brown B. S., Glendinning S. T. Neonatal effects of heroin addiction and methadone-treated pregnancies. Preliminary report on 70 live births. Proc Natl Conf Methadone Treat 1973; 2: 1153-64.
90. Doberczak T. M., Kandall S. R., Friedmann P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993; 81: 936-40.
91. Fajemirokun-Odudeyi O., Sinha C., Tutty S., Pairaudeau P., Armstrong D., Phillips T. et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol 2006; 126: 170-5.
92. Finnegan L. P. Management of pregnant drug-dependent women. Ann NY Acad Sci 1978; 311: 135-46.
93. Green M., Silverman I., Suffet F., Taleporos E., Turkel W. V. Outcomes of pregnancy for addicts receiving comprehensive care. Am J Drug Alcohol Abuse 1979; 6: 413-29.
94. Harper R. G., Solish G. I., Purow H. M., Sang E., Panepinto W. C. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants. Pediatrics 1974; 54: 300-5.
95. Johnson K., Greenough A., Gerada C. Maternal drug use and length of neonatal unit stay. Addiction 2003; 98: 785-9.
96. Kakko J., Heilig M., Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008; 96: 69-78.
97. Kandall S. R., Doberczak T. M., Mauer K. R., Strashun R. H., Korts D. C. Opiate v CNS depressant therapy in neonatal drug abstinence syndrome. Am J Dis Child 1983; 137: 378-82.
98. Morrison C. L., Siney C., Ruben S. M., Worthington M. Obstetric liaison in drug dependency. Eur Addict Res 1995; 3: 93-101.
99. Offidani C., Chiarotti M., De Giovanni N., Falasconi A. M. Methadone in pregnancy: clinical-toxicological aspects. J Toxicol Clin Toxicol 1986; 24: 295-303.
100. Rohrmeister K., Bernert G., Langer M., Fischer G., Weninger M., Pollak A. [Opiate addiction in gravidity-consequences for the newborn. Results of an interdisciplinary treatment concept]. Z Geburtsh Neonatol 2001; 205: 224-30.
101. Rosen T. S., Johnson H. L. Long-term effects of prenatal methadone maintenance. Current research on the consequences of maternal drug abuse. NIDA Monogr 1985; 59: 73-83.
102. Scott N. R., Ryan J. J. Clinical evaluation of pregnant methadone maintenance patients and their newborn infants. Proc Natl Conf Methadone Treat 1973; 2: 1128-32.
103. Vucinovic M., Roje D., Vucinovic Z., Capkun V., Bucat M., Banovic I. Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience. Yonsei Med J 2008; 49: 705-13.
104. Wilson G. S., Desmond M. M., Wait R. B. Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications. J Pediatr 1981; 98: 716-22.
105. Wolff K., Boys A., Rostami-Hodjegan A., Hay A., Raistrick D. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005; 61: 763-8.